Feb 9 (Reuters) – Shield Therapeutics PLC: * SHIELD THERAPEUTICS – FDA GRANTS ADDITIONAL EXCLUSIVITY FOR ACCRUFER * SHIELD THERAPEUTICS : EXCLUSIVITY REMAINS IN PLACE UNTIL 19 DEC 2028 IN ADDITION TO ACCRUFER/FERACCRU PATENT COVERAGE VALID UNTIL MID-2030S Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Berlin (dpa) – Chocolate can be comforting, a special treat or a consolation prize. But…
By Rae Wee SINGAPORE, Oct 5 (Reuters) - Stocks were off to a strong start…
By Leika Kihara TOKYO, Oct 5 (Reuters) - Bank of Japan Deputy Governor Shinichi Uchida…
The following factors could affect Italian markets on Monday. Reuters has not verified the newspaper…
Carolina's Bryce Young threw two touchdown passes to Tetairoa McMillan and the injury-riddled Panthers defense…
* Shared currency drops sharply vs dollar, sterling, Swiss franc * Safe haven demand and…